Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 29:14:2879-2892.
doi: 10.2147/OTT.S299234. eCollection 2021.

MiR-140-3p Impedes Gastric Cancer Progression and Metastasis by Regulating BCL2/BECN1-Mediated Autophagy

Affiliations

MiR-140-3p Impedes Gastric Cancer Progression and Metastasis by Regulating BCL2/BECN1-Mediated Autophagy

Jianliang Chen et al. Onco Targets Ther. .

Abstract

Introduction: MiRNAs have been proven to modulate the progression of gastric cancer (GC). In this field, we evaluated the role and mechanism of miR-140-3p in GC.

Methods: Western blotting and qRT-PCR were used to detect the levels of miR-140-3p and BCL2. The interaction of miR-140-3p and BCL2 was confirmed by dual-luciferase reporter and miRNA pull-down assays. CCK-8, EdU, wound healing, and Transwell invasion assays were performed to evaluate cell proliferation, migration and invasion. Autophagy was analyzed using Western blot analysis of the LC3-II/I ratio and immunofluorescence staining. A xenograft model was established to reveal the role of miR-140-3p in tumorigenesis.

Results: In GC cell lines and tissues, miR-140-3p was highly expressed, and BCL2 was expressed at low levels. MiR-140-3p directly inhibited BCL2 expression and indirectly promoted BECN1 expression, and BCL2 inhibited BECN1 expression. MiR-140-3p overexpression or silencing restrained or facilitated migration, invasion and EMT in GC cells. Moreover, we noticed that overexpression or downregulation of miR-140-3p promoted or suppressed BECN1-dependent autophagy in GC cells. BCL2 introduction or BECN1 silencing in GC cells partially blocked the effects of miR-140-3p. In conclusion, miR-140-3p directly downregulated the expression of BCL2, BCL2 downregulation further activated BECN1-dependent autophagy, and autophagy activation further inhibited EMT.

Conclusion: miR-140-3p may act as a tumor suppressor by targeting BCL2 and regulating downstream BECN1-induced autophagy and metastasis in GC progression.

Keywords: BCL2; BECN1; EMT; autophagy; gastric cancer; miR-140-3p.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests in this work.

Figures

Figure 1
Figure 1
MiR-140-3p was downregulated in GC tissues and cell lines.
Figure 2
Figure 2
MiR-140-3p directly targeted BCL2 in GC cell lines.
Figure 3
Figure 3
BCL2 was negatively regulated by miR-140-3p in GC tissues and cell lines.
Figure 4
Figure 4
MiR-140-3p inhibits proliferation and promotes apoptosis by targeting BCL2.
Figure 5
Figure 5
MiR-140-3p inhibited migration and invasion and enhanced autophagy by targeting BCL2.
Figure 6
Figure 6
BECN1 interfered with autophagy regulated by miR-140-3p in GC cell lines.
Figure 7
Figure 7
BECN1 interfered with migration, invasion and EMT regulated by miR-140-3p. (A) A wound healing assay was used to detect the migration of BGC-823 and MKN45 cells; scale bar = 100 μm. (B) A Transwell assay was used to detect cell invasion; scale bar = 100 μm. (C) The protein expression of Vimentin, N-cadherin, E-cadherin, and LC3 II/I was determined using Western blot analysis. *P<0.05; **P<0.01; ***P<0.001.
Figure 8
Figure 8
MiR-140-3p regulated tumorigenesis in a nude mouse model.

References

    1. Bray F, J-Ferlay I, Soerjomataram RL, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492 - DOI - PubMed
    1. Ang TL, Fock KM. Clinical epidemiology of gastric cancer. Singapore Med J. 2014;55:621–628. doi:10.11622/smedj.2014174 - DOI - PMC - PubMed
    1. Sitarz R, Skierucha M, Mielko J, et al. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–248. doi:10.2147/CMAR.S149619 - DOI - PMC - PubMed
    1. Marrelli DA, De Stefano G, de Manzoni P, et al. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241:247–255. doi:10.1097/01.sla.0000152019.14741.97 - DOI - PMC - PubMed
    1. Yu S, Li G, Wang Z, et al. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer. Tumour Biol. 2016;37:15007–15017. doi:10.1007/s13277-016-5383-5 - DOI - PubMed

LinkOut - more resources